Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. 

Biotechnology

Attralus Therapeutics

Attralus Therapeutics' headquarters in South San Francisco, CA, United States

The Burlingame office likely supports scientific research and high-level executive administrative functions.

Burlingame

Mark Timney

Joseph Suttner

Stephanie Beighley

Amy Rocca

Jim Carlson

Christine Huh

James Testa

Jonathan Wall

Glen Firestone

Gregory Bell

Rahul Kakkar

Jeff Kelly

Mathew Maurer

Jake Bauer

Alexander Denner

Corey Goodman

Morie Gertz

Nancy Miller-Rich

Richard Gaster

Jaume Pons

This department provides strategic direction and governance for the organization.

Executive Leadership

The Regulatory and Scientific Development team at Attralus Therapeutics is responsible for guiding the regulatory strategy and scientific rigor behind the development of transformative therapies for systemic amyloidosis. This team collaborates closely across disciplines to ensure compliance with regulatory standards, facilitates product development from laboratory to clinic, and engages with health authorities to advance therapeutic candidates effectively through the pipeline. Their expertise encompasses regulatory affairs, quality assurance, CMC (chemistry, manufacturing, and controls), toxicology, and analytical development, ensuring that Attralus's innovations meet the highest safety and efficacy standards.

Regulatory and Scientific Development

The Clinical Operations and Development team at Attralus Therapeutics is responsible for overseeing the design, planning, and execution of clinical trials aimed at evaluating potential treatments for systemic amyloidosis. This team ensures compliance with regulatory standards, manages project timelines, and coordinates cross-functional efforts to facilitate data collection and analysis, ultimately driving the progression of innovative therapies from the lab to patients.

Clinical Operations and Development

This department focuses on the development and implementation of statistical programming solutions for clinical trials.

Clinical Programming

This department focuses on strategic growth initiatives, partnerships, and business opportunities to enhance the company's market position.

Corporate Development

This department oversees compliance with regulatory requirements and manages the organization's financial strategies.

Attralus Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Regulatory and Scientific Development

Clinical Operations and Development

Clinical Programming

Corporate Development

Regulatory and Finance

Offices

Attralus Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Regulatory and Scientific Development

Clinical Operations and Development

Clinical Programming

Corporate Development

Regulatory and Finance

Offices

Related companies